Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

BUY
$2.25 - $5.24 $1,197 - $2,787
532 Added 0.7%
76,883 $0
Q4 2019

Feb 14, 2020

BUY
$3.08 - $5.9 $890 - $1,705
289 Added 0.38%
76,351 $0
Q2 2019

Aug 14, 2019

BUY
$8.51 - $14.95 $647,287 - $1.14 Million
76,062 New
76,062 $0

Others Institutions Holding AXLA

About Axcella Health Inc.


  • Ticker AXLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,500,896
  • Description
  • Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...
More about AXLA
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.